
From Lab to Life: How Boston IVF is Reshaping Fertility
About this episode
As more people either delay or seek alternative routes to starting families, fertility care has become a vital part of modern healthcare. In this episode of Health Care in Action, Boston IVF CEO David Stern takes us inside the cutting-edge world of in-vitro fertilization (IVF). Learn how advancements in embryo culture, genetic testing, and AI are improving success rates and creating personalized treatment plans. David also shares how Boston IVF’s innovative approach to patient care is making fertility treatment more accessible and breaking down common barriers like cost, travel, and stigma.
Key takeaways from this episode:
- How advancements in embryo culture and genetic testing have dramatically improved success rates while reducing risks like multiple births
- How Boston IVF's hub-and-spoke model makes treatment more accessible and convenient, addressing common barriers like cost and travel time
- How new technologies like AI and customized patient management systems are reshaping the IVF landscape
- Why addressing the stigma of infertility is important to bridging the communication gap between patients and practitioners
To learn more about THL’s cross-sector strategy to uncover opportunities in emerging technologies, visit THL.com/automation
Get every episode summarized
Each time Healthcare in Action publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Healthcare in Action

Bayada Home Health Care: Purpose, Performance, and the Bayada Way
Healthcare in Action

Connected Intelligence: Mosai's AI-Powered Platform for Home-Based Care
Healthcare in Action

Healthcare Distribution and Lessons from Leading a Fortune 15 Healthcare Company
Healthcare in Action

Advancing Drug Development with Real World Data
Healthcare in Action